The Jackson Laboratory

Forum for Discovery is JAX's annual event that brings together leading researchers focused on genomic solutions for critical health challenges, while also expressing gratitude to those who support these efforts.

Jul

16

2026

About

Step into the future of science at JAX’s annual Forum for Discovery where we showcase our groundbreaking research and bold ideas to tackle today’s biggest health challenges and shape a healthier tomorrow. Here's a look at this year's program.

Schedule at a glance

2:00 p.m. | Opening remarks
Christine Lin Egli, Vice President of Advancement                             

 2:05 p.m. | State of the Laboratory
Lon Cardon, Ph.D., FMedSCi, President and Chief Executive Officer

2:25 p.m. | Session I: The New Era of Biomedical Research
Daniel Paull, Ph.D., Scientific Director, JAX-NYSCF and Vice President, Discovery & Platform Development
Matt Mahoney, Ph.D., Principal Computational Scientist

Last fall, JAX's acquisition of The New York Stem Cell Foundation (NYSCF) marked a bold new era of biomedical discovery. CARDIOVERSE, a project that combines AI, stem cells and genetic variation to predict drug safety before human trials, represents one of the major leaps made possible by the union of JAX and NYSCF. The initiative leverages NYSCF's stem cell technologies and JAX's computational expertise to build virtual human hearts that can predict cardiotoxicity in drugs before testing them on patients. See how CARDIOVERSE is poised to transform how new therapies are developed.

2:55  p.m. | BREAK

3:10 p.m. | Reflections on a summer at JAX
2026 Summer Students

Two 2026 Summer Student Program Participants – driven by curiosity and excited by discovery will share what it is like to spend a transformative summer immersed in research at JAX.

3:25 p.m. | Session II: The Human Impact of the Maine Cancer Genomics Initiative – a Fireside Chat
Moderator: Christine Lin Egli
Philip Brooks, M.D., Physician, Eastern Maine Medical Center Cancer
Cora Fahy, Patient Advocate and Cancer Survivor
Jens Rueter, Ph.D., Chief Medical Officer, Medical Director, Maine Cancer Genomics Initiative

The Maine Cancer Genomics Initiative (MCGI) is closing the gaps in cancer care through the voices of those closest to it. As MCGI celebrates its 10th year of impact, its story of success underscores the power of collaboration between patients, physicians, and global experts to ensure every patient has access to the same cancer care—changing outcomes and delivering hope closer to home.

4:00 p.m. | Closing remarks
Christine Lin Egli

4:05 p.m. | In-person networking reception

5:00 p.m. | Reception concludes

Registration opens soon!

Questions? Contact [email protected].

Meet the Speakers

august 2017 Philip Brooks

Philip Brooks

M.D.

Physician, Eastern Maine Medical Center Cancer Care

Meet Philip
lon-cardon

Lon Cardon

Ph.D., FMedSci

President and CEO

Meet Lon

Cora Fahy

Patient Advocate, Breast Cancer Survivor

Meet Cora
Christine Lin, JAX GM, Farmington, April 8, 2026

Christine Lin Egli

Vice President, Advancement

Meet Christine
Matt Mahoney Headshot 2025

Matt Mahoney

Ph.D.

Principal Computational Scientist

Meet Matt
Daniel Paull Headshot 2025

Daniel Paull

Ph.D.

Scientific Director, JAX-NYSCF and Vice President, Discovery & Platform Development

Meet Daniel

Jens Rueter

M.D.

Chief Medical Officer, JAX; Medical Director, MCGI

Meet Jens

Thank you to our 2026 sponsors

Past Event Recordings:

©2026 The Jackson Laboratory